Exploring the link between autoimmune diseases and Alzheimer's Disease in diverse populations
Investigating clinical risk between autoimmunity and Alzheimer’s Disease in diverse human populations
['FUNDING_FELLOWSHIP'] · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · NIH-10996024
This study is looking at whether people with autoimmune diseases are more likely to develop Alzheimer's Disease, and it aims to find out how factors like gender and ethnicity might play a role, all to help improve understanding and treatment of these conditions.
Quick facts
| Phase | ['FUNDING_FELLOWSHIP'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO (nih funded) |
| Locations | 1 site (SAN FRANCISCO, UNITED STATES) |
| Trial ID | NIH-10996024 on ClinicalTrials.gov |
What this research studies
This research investigates the relationship between autoimmune diseases and the risk of developing Alzheimer's Disease (AD) by analyzing real-world clinical data from electronic health records. The study aims to determine if individuals with autoimmune conditions have a higher likelihood of developing AD, focusing on various demographic factors such as gender and ethnicity. By examining these connections, the research seeks to uncover potential shared mechanisms between autoimmune diseases and AD, which could lead to new insights into disease prevention and treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with autoimmune diseases, particularly those who are at risk for Alzheimer's Disease.
Not a fit: Patients without autoimmune diseases or those already diagnosed with Alzheimer's Disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding of Alzheimer's Disease risk factors, potentially informing prevention strategies for at-risk populations.
How similar studies have performed: While the investigation of autoimmune diseases in relation to Alzheimer's Disease is relatively novel, there is emerging evidence suggesting immune dysfunction may play a role in neurodegenerative conditions.
Where this research is happening
SAN FRANCISCO, UNITED STATES
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO — SAN FRANCISCO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: RAMEY, GRACE — UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
- Study coordinator: RAMEY, GRACE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Alzheimer disease dementia, Alzheimer syndrome, Alzheimer's Disease, Alzheimer's disease risk